GO:0098615 dimethyl selenide methyltransferase activity

Dimethyl selenide methyltransferase activity (GO:0098615) is a molecular function that catalyzes the methylation of dimethyl selenide to form trimethylselenonium, using S-adenosyl-L-methionine (SAM) as the methyl donor. This reaction is part of the selenium detoxification and excretion pathway, converting a volatile, potentially toxic selenium metabolite into a more water-soluble and excretable form. The enzyme responsible for this activity, thioether S-methyltransferase (TEMT), has been studied for its ability to methylate various thioether substrates, including dimethyl selenide. Understanding this activity is important for researchers investigating selenium homeostasis, detoxification mechanisms, and the role of selenium in health and disease. The suicide inactivation of TEMT by ethyl sulfide provides a unique window into the catalytic mechanism and regulation of this enzyme. As selenium compounds are increasingly recognized for their roles in cancer prevention and toxicity, precise tools to study GO:0098615 are essential.

GO:0098615 is defined as the catalysis of the reaction: S-adenosyl-L-methionine + dimethyl selenide = S-adenosyl-L-homocysteine + trimethylselenonium. In other words, it is the enzymatic activity that transfers a methyl group from SAM to dimethyl selenide, yielding trimethylselenonium and SAH.

GO:0098615 is important because it represents a critical step in selenium detoxification, converting the volatile and toxic dimethyl selenide into the excretable trimethylselenonium ion. This activity helps maintain selenium homeostasis and prevents selenium toxicity, which can cause selenosis. Moreover, selenium metabolites have been implicated in cancer chemoprevention, and understanding their metabolism may reveal new therapeutic targets. The suicide inactivation of TEMT by ethyl sulfide also provides a model for studying enzyme regulation and mechanism-based inhibition.

The following genes and proteins are associated with dimethyl selenide methyltransferase activity or related selenium metabolism pathways.

The activity of dimethyl selenide methyltransferase is primarily regulated by substrate availability (SAM and dimethyl selenide) and product inhibition (SAH). Suicide inactivation by ethyl sulfide represents a mechanism-based regulation that can permanently downregulate enzyme activity. Additionally, the expression of the TEMT gene may be influenced by selenium status and other metabolic factors, though specific transcriptional regulators have not been fully elucidated.

Impaired dimethyl selenide methyltransferase activity could lead to accumulation of toxic selenium metabolites, contributing to selenosis, which is characterized by hair loss, nail brittleness, and neurological symptoms. Enhancing this activity may help detoxify excess selenium.

Selenium metabolites, including trimethylselenonium, have been studied for their role in cancer prevention. The methylation of dimethyl selenide may influence the bioavailability of anticancer selenium species. Understanding this pathway could inform the use of selenium in cancer prevention strategies.

Selenium imbalance has been linked to neurodegenerative diseases. Proper regulation of selenium detoxification via methylation may protect against selenium-induced neurotoxicity.

Direct measurement of dimethyl selenide methyltransferase activity can be performed using radiolabeled SAM and detecting the formation of trimethylselenonium by HPLC or mass spectrometry. These assays are essential for characterizing enzyme kinetics and inhibition.

CRISPR-Cas9 can be used to generate knockout, point mutation, knock-in, or overexpression models for genes involved in this activity, such as TEMT. These models enable functional studies in relevant cell lines and animal models.

RNA-seq and proteomics can reveal changes in gene expression and protein levels in response to selenium status or genetic perturbations, providing insights into the broader regulatory network.

Metabolomic profiling can quantify selenium metabolites, including dimethyl selenide and trimethylselenonium, to assess pathway flux and detoxification efficiency.

Researchers studying dimethyl selenide methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in selenium metabolism, detoxification, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.

Dimethyl selenide methyltransferase activity (GO:0098615) is a vital enzymatic function in selenium detoxification, catalyzing the methylation of dimethyl selenide to trimethylselenonium. Understanding its mechanism, regulation, and role in disease can provide insights into selenium biology and potential therapeutic interventions. CRISPR-based models offer powerful tools to dissect this activity and its associated genes, paving the way for future research and applications.